Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II of oral satraplatin in patients with metastatic breast cancer (MBC).

Trial Profile

Phase II of oral satraplatin in patients with metastatic breast cancer (MBC).

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2012

At a glance

  • Drugs Satraplatin (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 22 Mar 2012 Actual patient (40) as reported by ClinicalTrials.gov.
    • 14 Feb 2008 The expected completion date for this trial is now 1 Feb 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top